In connection with the implementation of the project entitled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological safety” funded by the state budget from the Medical Research Agency, Zakłady Farmaceutyczne Polpharma S.A., are requesting bids for the provision of services for a consulting service related to risk assessment and cost estimation regarding the implementation of a Quality System compliant with US-FDA requirements at Pharmaceutical Works Polpharma, Branch in Starogard Gdański.
Details of the price inquiry can be found in the documents attached.
